Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03981445 · ClinicalTrials.gov registry record · NA

Integrated HIV Prevention and HCV Care for PWID

A NA study of Opioid Use and HIV Prevention, sponsored by Columbia University.

Active
Registry status
NA
Development phase
446
Enrollment target
3
Study locations

NCT03981445 is a NA study of Opioid Use and HIV Prevention that is active but no longer recruiting, run by Columbia University. The registered enrollment target is 446 participants, below the 148,256-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03981445, a NA study of Opioid Use and HIV Prevention, is active but no longer recruiting, sponsored by Columbia University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
446 participants
Enrollment target
3
Study locations

Study Summary

The objective of this study is to compare and evaluate two strategies of delivering PrEP and Hepatitis C Virus (HCV) treatment to people who inject drugs to determine the best method of providing care. Participants will be randomized to one of two treatment arms: on-site integrated care or off-site referral to specialized care.

Conditions Studied

Opioid Use HIV Prevention HCV Intravenous Drug Usage

Interventions

  • BEHAVIORAL ARTAS Adapted Patient Navigation
  • BEHAVIORAL Adherence Counseling

Study Locations (3)

Florida

  • Miami - Miami

New York

  • Columbia University Irving Medical Center - New York

Quebec

  • Montreal - Montreal

Trial Details

FieldValue
Enrollment Target 446 participants
Start Date 2019-11-14
Est. Completion 2025-12-31
Phase NA

Sponsor

Columbia University

958 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03981445

The ClinicalTrials.gov registry entry for NCT03981445 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 446 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 148,256-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Opioid Use appearing as the primary indexed condition, and to 2 interventions - of which ARTAS Adapted Patient Navigation is the first listed.

NCT03981445 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, New York, Quebec.

Frequently Asked Questions

What is clinical trial NCT03981445 about?

NCT03981445 is a clinical study titled "Integrated HIV Prevention and HCV Care for PWID". The objective of this study is to compare and evaluate two strategies of delivering PrEP and Hepatitis C Virus (HCV) treatment to people who inject drugs to determine the best method of providing care. Participants will be randomized to one of two treatment arms: on-site integrated care or off-site ...

What is the current status of trial NCT03981445?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 446 participants. The study started on 2019-11-14. Estimated completion is 2025-12-31.

What conditions does trial NCT03981445 study?

This clinical trial studies the following conditions: Opioid Use, HIV Prevention, HCV, Intravenous Drug Usage.

What interventions are being tested in trial NCT03981445?

The interventions under investigation include: ARTAS Adapted Patient Navigation (BEHAVIORAL), Adherence Counseling (BEHAVIORAL).

Who is sponsoring clinical trial NCT03981445?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03981445 being conducted?

This trial has 3 study locations across Florida, New York, Quebec. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Opioid Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Opioid Use

All registered trials for this condition

HIV Prevention

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.